false

Vincent Shortino

Vincent Shortino is a Principal Clinical Trial Manager, bringing more than 20 years of experience to Precision. His experience spans all major therapeutic areas with a heavy emphasis on Cardiovascular and Rare Indications, across Phases I–IV. He brings solid perspectives inclusive of sites, pharma and CROs from his previous roles of Study Coordinator, Site Director, CRA, and Clinical Trial Manager.

• Read: Lessons Learned from a Rare Pediatric Case Study

  Lessons Learned from a Rare Pediatric Case Study

  Aug 12, ‘24 | 6 min read

  • 

    Vincent Shortino

  Discover
• Read: Optimizing Investigator Databases for Oncology Trial Enrollment

  Clinical Trials - Oncology

  Optimizing Investigator Databases for Oncology Trial Enrollment

  Apr 10, ‘24 | 3 min read

  • 

    Vincent Shortino

  Discover
• Read: Inside a CRO: The Pivotal Role of Clinical Trial Manager in Clinical Research

  Clinical Trials

  Inside a CRO: The Pivotal Role of Clinical Trial Manager in Clinical Research

  Dec 05, ‘23 | 3 min read

  • 

    Vincent Shortino

  Discover
• Read: Decentralized Clinical Trials: Strategies that Work in Rare Diseases

  Clinical Trials

  Decentralized Clinical Trials: Strategies that Work in Rare Diseases

  Jun 07, ‘23 | 5 min read

  • 

    Vincent Shortino

  Discover
• Read: Centralized vs Decentralized Raters: When to Use Which in CNS Trials?

  Clinical Trials

  Centralized vs Decentralized Raters: When to Use Which in CNS Trials?

  May 12, ‘23 | 5 min read

  • 

  • Rob M.

    Vincent S.

  Discover
• Read: Advancing the Use of Biomarkers in CNS Drug Discovery and Development

  Clinical Trials - Biomarkers

  Advancing the Use of Biomarkers in CNS Drug Discovery and Development

  Mar 09, ‘23 | 4 min read

  • 

  • Tracey O.

    Vincent S.

  Discover
• Read: Using electronic patient-reported outcome (ePRO) technology to address key challenges in CNS trials

  Clinical Trials

  Using electronic patient-reported outcome (ePRO) technology to address key challenges in CNS trials

  Feb 08, ‘23 | 4 min read

  • 

  • Tracey O.

    Vincent S.

  Discover
• Read: Phase 1/2 Combination Studies: Best Practices When Moving from Escalation to Expansion

  Clinical Trials - Early Phase Research - Oncology

  Phase 1/2 Combination Studies: Best Practices When Moving from Escalation to Expansion

  Jan 25, ‘23 | 6 min read

  • 

    Vincent Shortino

  Discover
• Read: Shifting the Paradigm in Personalized Medicine Clinical Trials

  Clinical Trials - Biomarkers

  Shifting the Paradigm in Personalized Medicine Clinical Trials

  Oct 14, ‘22 | 1 min read

  • 

    Vincent Shortino

  Discover

Loading...

You've reach the end Back to top